Abstract
This study aims to systematically evaluate the efficacy and safety of vitamin B12 acupoint injections compared to other administration routes in treating diabetic neuropathy (DN). We included 20 randomized controlled trials published before March 1, 2024, sourced from eight public databases, involving 1688 participants. Subsequently, we recorded their basic data, investigated their risk of bias, and then carried out a meta-analysis and trial sequential analysis (TSA). The meta-analysis revealed that compared to other administration routes of vitamin B12, acupoint injection significantly improved the clinical effectiveness proportion by 28% (risk ratio [RR] 1.28, 95% confidence interval [CI] 1.22–1.35), peroneal nerve motor nerve conduction velocity (MNCV) by 4.43 m/s (MD 4.43, 95% CI 2.83–6.03), peroneal nerve sensory nerve conduction velocity (SNCV) by 3.82 m/s (MD 3.82, 95% CI 3.23–4.41), median nerve MNCV by 5.48 m/s (MD 5.48, 95% CI 4.71–6.24), and median nerve SNCV by 4.62 m/s (MD 4.62, 95% CI 3.84–5.39) in patients with DN, while having no significant impact on fasting blood glucose (FBG) (MD −0.18, 95% CI −0.44 to 0.08), 2-h postprandial blood glucose (2h-PBG) (MD −0.02, 95% CI −0.36 to 0.33), and the adverse event incidence (RR 1.44, 95% CI 0.44–4.70). TSA indicated that except for FBG, 2h-PBG, and adverse event incidence, the remaining meta-analysis results were conclusive. These findings indicate that compared to other administration routes of vitamin B12, acupoint injection improves neurological function in patients with DN without increasing adverse events and economic burden, suggesting that it may be the optimal administration route for vitamin B12.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
The data from this study are available upon request to the corresponding author.
References
Tabish SA. Is Diabetes becoming the biggest epidemic of the twenty-first century?. Int J Health Sci. 2007;1:5–8.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab Res Clin Pr. 2022;183:109119.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Prim. 2019;5:42.
Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diab Endocrinol. 2019;7:938–48.
Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;2012:CD007543.
Schlesinger S, Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diab care. 2019;42:240–7.
Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:89–94.
Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diab Care. 2003;26:1790–5.
Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314:2172–81.
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.
Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G, et al. Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13:395.
Ryan-Harshman M, Aldoori W. Vitamin B12 and health. Can Fam Phys. 2008;54:536–41.
Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med. 2009;22:528–34.
Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diab Obes Metab. 2022;24:1423–8.
Schleicher E, Didangelos T, Kotzakioulafi E, Cegan A, Peter A, Kantartzis K. Clinical pathobiochemistry of vitamin B12 deficiency: improving our understanding by exploring novel mechanisms with a focus on diabetic neuropathy. Nutrients. 2023;15:2597.
Randaccio L, Geremia S, Demitri N, Wuerges J. Vitamin B12: unique metalorganic compounds and the most complex vitamins. Molecules. 2010;15:3228–59.
Thakkar K, Billa G. Treatment of vitamin B12 deficiency-methylcobalamine? Cyancobalamine? Hydroxocobalamin?-clearing the confusion. Eur J Clin Nutr. 2015;69:1–2.
Buesing S, Costa M, Schilling JM, Moeller-Bertram T. Vitamin B12 as a treatment for pain. Pain Physician. 2019;22:E45–E52.
Yazidi M, Kamoun E, Hadj Taieb S, Rejeb O, Mahjoub S, Maryam S, et al. Vitamin B12 deficiency in long-term metformin treated type 2 diabetic patients: prevalence and risk factors in a Tunisian population. Chronic Illn. 2024;20:631–9.
Tandon R, Thacker J, Pandya U, Patel M, Tandon K. Parenteral vs oral vitamin B12 in children with nutritional macrocytic anemia: a randomized controlled trial. Indian Pediatr. 2022;59:683–7.
Elangovan R, Baruteau J. Inherited and acquired vitamin B12 deficiencies: which administration route to choose for supplementation?. Front Pharm. 2022;13:972468.
Wang Z, Shi X. Research progress of acupoint injection in treating diabetic peripheral neuropathy China’s. Naturopathy. 2022;30:121–5.
Oh JE, Kim SN. Anti-inflammatory effects of acupuncture at ST36 point: a literature review in animal studies. Front Immunol. 2021;12:813748.
Zhu J, Li J, Yang L, Liu S. Acupuncture, from the ancient to the current. Anat Rec. 2021;304:2365–71.
Sha T, Gao LL, Zhang CH, Zheng JG, Meng ZH. An update on acupuncture point injection. QJM Monthly J Assoc Phys. 2016;109:639–41.
Feng Y, Fang Y, Wang Y, Hao Y. Acupoint therapy on diabetes mellitus and its common chronic complications: a review of its mechanisms. BioMed Res Int. 2018;2018:3128378.
Liu L, Jiang C, Zhao Z. Effects of salvia miltiorrhiza Ligustrazine injection combined with mecobalamin on diabetic peripheral neuropathy and oxidative stress response. Chin Herb Med. 2019;50:2670–4.
Zhou J, Li X, Liang Y, Wang Z. Efficacy of acupoint injection of methycobal in the treatment of diabetic peripheral neuropathy in 45 cases. J Clin Acupunct Moxibustion. 2005;2005:39–40+67.
Li S, Wang K, Hou J, Yan H, Li J. Clinical research progress on external treatment of traditional Chinese medicine in the treatment of diabetic peripheral neuropathy. Yunnan J Traditional Chin Med Mater Med. 2018;39:82–84.
Chen H, Ma G, Ye T, Tian Y. Clinical observation on the treatment of diabetic lower limb neuropathy by acupoint injection of methycobal. J Clin Acupunct Moxibustion. 2012;28:41–42.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Cao R. Mecobalamin Zusanli acupoint injection in adjuvant treatment on diabetic peripheral neuropathy of lower limb. Hebei Med. 2015;21:323–5.
Chen D, Yu J. Clinical observation on acupuncture point injection methycobal for diabetic peripheral neuropathy of four extremity. J Clin Acupunct Moxibustion. 2015;31:39–42.
Deng X, Zhao W, Tang A, Li S, Liu C, Luo G, et al. Acupoint injection of methycobal to treat diabetes observation on the efficacy of neuropathy. J Guangxi Univ Chin Med. 2007;2007:17–19.
Guo H, Zhao S, Li C, Guo Y, Zhang X. Clinical experience of methylcobalamin Zusanli acupoint injection in the treatment of diabetic peripheral neuropathy. In: Proceedings of the 3rd Shandong Province Academic Symposium on Integrated Traditional Chinese and Western Medicine Neurology, pp320–323. Neurology Professional Committee of Shandong Association of Integrative Medicine: Jinan, Shandong, China; 2011.
Huang C. Efficacy of cobamamide injection at acupoints on DPN. Clin J Chin Med. 2018;10:55–57.
Li Z, He F, Xiao H, Zhang K. Methylcobalamin acupoint injection in the treatment of diabetic peripheral neuropathy. Qingdao Med J. 2009;41:36–37.
Liu Y. Exploration of the efficacy and safety of different injection modalities of methylcobalamin in diabetic peripheral neuropathy. Chin Sci Technol J Database. 2021;2021:0097–8.
Mo G, Tan L, Huang X. Clinical observation on 40 cases of diabetic peripheral neuropathy treated with methylcobalamin acupoint injection. Jiangsu J Traditional Chin Med. 2011;43:63–64.
Sun J, Han Y. Observation on the efficacy of methylcobalamin acupoint injection in the treatment of diabetic lower limb peripheral neuropathy. Mod J Integr Traditional Chin West Med. 2011;20:2512–3.
Wen X. Clinical observation on the treatment of peripheral neuropathy in type 2 diabetes mellitus with methylcobalamin acupoint injection. J North Pharm. 2014;11:30–31.
Wu L, Liu Y, Tang Q, Wang R, Xi F, Zhang T, et al. Influence of point injection with meridian fiowing Na Zhi method on diabetic patients with peripheral neuropathy. Chin Nurs Res. 2015;29:3418–9.
Xie Q, Hua D, Zhang L, Chen X. Observation on the efficacy of drug acupoint injection in the treatment of diabetic peripheral neuropathy. J Practical Traditional Chin Med. 2016;32:1189–90.
Xie Q, Chen D, Chen X. Effects of acupoint injection on serum SP in patients with diabetic peripheral neuropathy and clinical observation. Jiangxi J Traditional Chin Med. 2022;53:57–59.
Xu Z, Dong C, Ren M, Zhao X, Ma L, Zhang Y, et al. Observation on the efficacy of bilateral foot-sanli acupoint injection with adenosylcobalamin in patients with diabetic paralysis of the qi deficiency and blood stasis type. World Latest Med Inf. 2020;20:172–4.
Yang L, Li S, Zhu Y. Clinical study on 38 cases of diabetic peripheral neuropathy treated with methylcobalamin acupoint injection. Hebei J Traditional Chin Med. 2009;31:421–2.
Zhang L. Clinical study of acupuncture point injection in the treatment of diabetic peripheral neuropathy. Practical Clin J Integr Traditional Chin West Med. 2022;22:103–5+116.
Zhao C, Zhang X, Zhu J, Wang M, Dou Y, Wang J. Efficacy of acupoint injection of methylcobalamin combined with intravenous infusion of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Shanxi Med J. 2016;45:579–80.
Zhao D, Zhang F, Meng Y. Observations on the treatment of diabetic peripheral neuropathy by acupoint injection. Inf Traditional Chin Med. 2009;26:69–70.
Fei W, Shi X, Zhang D, Lian G. Observation of curative effect of vitamin B12 and its two active forms injections at Zusanli acupoint inthe treatment of diabetic distal symmetric polyneuropathy. Gansu Med J. 2022;41:705–7.
Funding
This study was funded by the National Natural Science Foundation of China [U21A20411].
Author information
Authors and Affiliations
Contributions
YYu and RY designed the study. YYu, TZ, and XL collected and organized data. LL and YYin performed the statistical analysis. YYu, TZ, XL, LL, and YYin wrote the manuscript. RY reviewed and revised the manuscript. All authors contributed to the article and approved the submitted version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study involved the review and analysis of published literature and did not involve any human or animal subjects. Therefore, ethical approval was not required.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yu, Y., Zhou, T., Li, L. et al. Acupoint injection increases the efficacy of vitamin B12 for diabetic neuropathy: a meta-analysis and trial sequential analysis. Eur J Clin Nutr (2025). https://doi.org/10.1038/s41430-025-01631-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41430-025-01631-z